Dec 16, 2021 / 12:20PM GMT
Patrik Ling - DNB Markets - Analyst
On with the next presenter, which is a Swedish medical technology company, Episurf Medical, and I have the pleasure to introduce the CEO, PÃ¥l Ryfors
So, PÃ¥l, the word is yours. So, take it away.
PÃ¥l Ryfors - Episurf Medical AB - CEO
Thank you very much, Patrik. So good afternoon, everyone. My name is PÃ¥l Ryfors, CEO of Episurf Medical. I would provide you with an update of Episurf's business today.
As a start, we have been in business now for about 10 years. We have spent a lot of time and resources on IP, on clinical activities and we are now really ready to take the next steps on our commercial journey, which will be a key focus for us in '22 and onwards.
The pandemic has been a tough period for us, of course, but we have actually essentially doubled the implant portfolio. So, we now are well over 1,000 patients treated and things are looking quite promising for us.
The original problem remains. You see a healthy knee on the left side and a treated knee on the right
Episurf Medical AB at DNB Nordic Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
